Pharma News
-
![The Neglected 'last mile' to Fight cancer]( "The Neglected 'last mile' to Fight cancer")
The Neglected 'last mile' to Fight cancer
2022-12-28The five-year survival rate of tumors is an important indicator of a country's tumor diagnosis and treatment ability.
-
![Consino Bio inhalation COVID-19 vaccine arrives in Morocco]( "Consino Bio inhalation COVID-19 vaccine arrives in Morocco")
Consino Bio inhalation COVID-19 vaccine arrives in Morocco
2022-12-28The first batch of Kvessa ® Bio-inhalation COVID-19 vaccine has arrived in Morocco, providing an innovative solution for local COVID-19 prevention.
-
![From 'Class B A Tube' to 'Class B B tube', where is the epidemic concept stock going?]( "From 'Class B A Tube' to 'Class B B tube', where is the epidemic concept stock going?")
From 'Class B A Tube' to 'Class B B tube', where is the epidemic concept stock going?
2022-12-28The history of "Class B A tube" has come to an end.
-
![Deqi Pharmaceutical and Merck reached a global clinical cooperation]( "Deqi Pharmaceutical and Merck reached a global clinical cooperation")
Deqi Pharmaceutical and Merck reached a global clinical cooperation
2022-12-28ATG-037 is an oral small molecule CD73 inhibitor from Deqi Pharmaceutical. KEYTRUDA® (Pbolizumab) is a PD-1 inhibitor of Merck.
-
![Huaxia Yingtai STAR-T project was approved as 'orphan drug' by FDA]( "Huaxia Yingtai STAR-T project was approved as 'orphan drug' by FDA")
Huaxia Yingtai STAR-T project was approved as 'orphan drug' by FDA
2022-12-27It marks that Huaxia Yingtai has entered a new stage of clinical development from new drug research and development.
-
![Supplement of spermidine enhances anti-tumor immune response]( "Supplement of spermidine enhances anti-tumor immune response")
Supplement of spermidine enhances anti-tumor immune response
2022-12-27Supplement of spermidine can enhance anti-tumor immune response mechanism!
-
![The vaccine got cold, and many CXOs couldn't sit still]( "The vaccine got cold, and many CXOs couldn't sit still")
The vaccine got cold, and many CXOs couldn't sit still
2022-12-27Three years of corona capital is coming to an end.
-
![Coronavirus' Drug mix 'Could Cause liver and Kidney Failure]( "Coronavirus' Drug mix 'Could Cause liver and Kidney Failure")
-
![Poinsettias: AR882 capsules approved for gout indication]( "Poinsettias: AR882 capsules approved for gout indication")
Poinsettias: AR882 capsules approved for gout indication
2022-12-23This product was tested for gout indication.
-
![Novocinogen Obutinib in combination with Tafasitamab and lenalidomide was approved for Phase II in China]( "Novocinogen Obutinib in combination with Tafasitamab and lenalidomide was approved for Phase II in China")
Novocinogen Obutinib in combination with Tafasitamab and lenalidomide was approved for Phase II in China
2022-12-23Tafasitamab is a humanized monoclonal antibody optimized for the Fc domain targeting CD19.
-
![The multi-dimensional support of 'clinBEST database' facilitates the clinical development of anti-tumor new drugs]( "The multi-dimensional support of 'clinBEST database' facilitates the clinical development of anti-tumor new drugs")
The multi-dimensional support of 'clinBEST database' facilitates the clinical development of anti-tumor new drugs
2022-12-23A practical tool for formulating and adjusting strategies for drug development in clinical oncology.
-
![NASH is on the verge of a new drug, and the 40-year black hole is finally shining a light]( "NASH is on the verge of a new drug, and the 40-year black hole is finally shining a light")
NASH is on the verge of a new drug, and the 40-year black hole is finally shining a light
2022-12-23A number of domestic pharmaceutical companies compete for the blue Ocean market
-
![Cp Tianqing plans to sell three subsidiaries]( "Cp Tianqing plans to sell three subsidiaries")
Cp Tianqing plans to sell three subsidiaries
2022-12-23Nanjing Pharmaceutical plans to acquire part or all of CP Tianqing's three controlling subsidiaries.
-
![Reindeer Biological self - developed CT103A clinical trial application approved by FDA!]( "Reindeer Biological self - developed CT103A clinical trial application approved by FDA!")
Reindeer Biological self - developed CT103A clinical trial application approved by FDA!
2022-12-23The approval of the CT103A US IND is an important milestone in the internationalization of reindeer biology.
-
![Kangvanda's first oncolytic vaccinia virus product V01 clinical application accepted]( "Kangvanda's first oncolytic vaccinia virus product V01 clinical application accepted")
Kangvanda's first oncolytic vaccinia virus product V01 clinical application accepted
2022-12-23It can treat a variety of solid tumors.
-
![Fosun Kat FKC889 was approved for clinical trials]( "Fosun Kat FKC889 was approved for clinical trials")
Fosun Kat FKC889 was approved for clinical trials
2022-12-23For the treatment of relapsed or refractory adult precursor B-cell acute lymphoblastic leukemia.
-
![Eu assessment of the efficacy of Bacillus Velez NRRL B-67259 as a feed additive for all growing poultry species]( "Eu assessment of the efficacy of Bacillus Velez NRRL B-67259 as a feed additive for all growing poultry species")
Eu assessment of the efficacy of Bacillus Velez NRRL B-67259 as a feed additive for all growing poultry species
2022-12-22After assessment, the Panel was unable to reach a conclusion on the efficacy of Bacillus Velez NRRL B-67259 as a feed additive for all growing poultry species.
-
![The European Union evaluates the safety of Lasaloxi sodium as a feed additive for fattening and laying hens]( "The European Union evaluates the safety of Lasaloxi sodium as a feed additive for fattening and laying hens")
The European Union evaluates the safety of Lasaloxi sodium as a feed additive for fattening and laying hens
2022-12-22European Union animal Feed Additives and Products (FEEDAP) research group issued A scientific opinion on the safety of lasalocid A sodium asa dietary additive for fattening chickens and laying hens.
-
![National Medical Insurance Administration held a meeting, anti-epidemic drugs will be reduced again! Health care negotiations are approaching]( "National Medical Insurance Administration held a meeting, anti-epidemic drugs will be reduced again! Health care negotiations are approaching")
National Medical Insurance Administration held a meeting, anti-epidemic drugs will be reduced again! Health care negotiations are approaching
2022-12-22We will do a good job in medical insurance at the end of the year and the beginning of the year, steadily advance the centralized procurement of dental implant consumables, and complete the adjustment of the 2022 medical insurance drug list.
-
![Phase II enrollment of ASC41(THRβ), an innovative pipeline drug developed by Lilly NASH, was successfully promoted]( "Phase II enrollment of ASC41(THRβ), an innovative pipeline drug developed by Lilly NASH, was successfully promoted")
Phase II enrollment of ASC41(THRβ), an innovative pipeline drug developed by Lilly NASH, was successfully promoted
2022-12-22Asc 41 is a liver targeting precursor drug independently developed by Golly.
-
Pharmaceutical Industry Overview
The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.Published in: Aug. 2024
Hot News
-
Top 10 Global CDMO Rankings in 2022
-
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody
-
Forecast of TOP 10 global best-selling drugs in 2021
-
Lilly's GLP-1 and Tirzepatide initiates phase III clinical trial
-
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
-
China State Drug Administration officially approved Semaglutide for type 2 diabetes
-
Top 30 best-selling oncology drugs in the world in 2020
-
Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use
-
Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial
-
AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
